Mitral valve replacement with heterologous aortic valves.
D000328:Adult; D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use; D001021:Aortic Valve / Q000637:transplantation*; D001795:Blood Pressure Determination; D002114:Calcinosis / Q000209:etiology; D006328:Cardiac Catheterization; D002417:Cattle; D014695:Cerebral Ventriculography; D004562:Electrocardiography; D005260:Female; D005465:Fluorocarbon Polymers; D005557:Formaldehyde; D006350:Heart Valve Prosthesis / Q000009:adverse effects / Q000401:mortality; D006491:Hemothorax / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000601:surgery; D008946:Mitral Valve Stenosis / Q000601:surgery; D009461:Neurologic Manifestations; D012131:Respiratory Insufficiency / Q000209:etiology; D013552:Swine; D013923:Thromboembolism / Q000209:etiology; D014183:Transplantation, Heterologous
D000925:Anticoagulants; D005465:Fluorocarbon Polymers; D005557:Formaldehyde